Carnosine
Carnosine is a dietary supplement with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Carnosine for Peripheral Arterial Disease Patients
Carnosine for Peripheral Arterial Disease
Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients
The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health
Clinical Trials (11)
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Carnosine for Peripheral Arterial Disease Patients
Carnosine for Peripheral Arterial Disease
Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients
The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health
Research on Prevention, Intervention and Mechanisms of Obesity and Its Comorbidities
Carnosine for Peripheral Vascular Disease
Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
Effect of Carnosine on Diabetes and Cardiovascular Risk Factors
The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk
Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes
All 11 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 11